Evaluation of adenomas per colonoscopy and adenomas per positive participant as new quality parameters in screening colonoscopy.


Journal

Gastrointestinal endoscopy
ISSN: 1097-6779
Titre abrégé: Gastrointest Endosc
Pays: United States
ID NLM: 0010505

Informations de publication

Date de publication:
03 2019
Historique:
received: 25 02 2018
accepted: 04 08 2018
pubmed: 24 8 2018
medline: 14 6 2019
entrez: 24 8 2018
Statut: ppublish

Résumé

The primary aim of this study was to evaluate adenomas per positive participant (APP) and adenomas per colonoscopy (APC) as new quality parameters in screening colonoscopy. Furthermore, we wanted to assess whether these parameters differ depending on the setting or profession. Colonoscopy records were obtained from the database of the Austrian certificate of quality for screening colonoscopy. The Spearman correlation was calculated to compare the adenoma detection rate (ADR), APC, APP, and advanced ADR. The parameters were compared between surgeons and internists and between private practices and hospitals by using the t test. A total of 44,142 colonoscopies performed by 202 endoscopists were included. APC showed a strong correlation with ADR (r = 0.94; P < .01), and both showed a similar correlation with the advanced ADR (ADR: r = 0.47; P < 0.01, APC: r = 0.46; P < .01). APP showed weaker correlations compared with all other parameters (ADR: r = 0.36; P < .01; advanced ADR: r = 0.19; P < .01). Private practices did not differ in ADR, APP or APC from hospitals. Among endoscopists with ADRs of ≥25%, 7 (10.3%) had an APP in the lowest quartile, whereas no endoscopists had an APC in the lowest quartile. APC did not reveal additional information to ADR, and thus there is no need to use it instead of or additionally to ADR. Although the APP identifies endoscopists who find few adenomas per procedure despite acceptable ADRs, this additional information might not be important in regard to sufficient colorectal cancer prevention, because these endoscopists still had high advanced ADRs.

Sections du résumé

BACKGROUND AND AIMS
The primary aim of this study was to evaluate adenomas per positive participant (APP) and adenomas per colonoscopy (APC) as new quality parameters in screening colonoscopy. Furthermore, we wanted to assess whether these parameters differ depending on the setting or profession.
METHODS
Colonoscopy records were obtained from the database of the Austrian certificate of quality for screening colonoscopy. The Spearman correlation was calculated to compare the adenoma detection rate (ADR), APC, APP, and advanced ADR. The parameters were compared between surgeons and internists and between private practices and hospitals by using the t test.
RESULTS
A total of 44,142 colonoscopies performed by 202 endoscopists were included. APC showed a strong correlation with ADR (r = 0.94; P < .01), and both showed a similar correlation with the advanced ADR (ADR: r = 0.47; P < 0.01, APC: r = 0.46; P < .01). APP showed weaker correlations compared with all other parameters (ADR: r = 0.36; P < .01; advanced ADR: r = 0.19; P < .01). Private practices did not differ in ADR, APP or APC from hospitals. Among endoscopists with ADRs of ≥25%, 7 (10.3%) had an APP in the lowest quartile, whereas no endoscopists had an APC in the lowest quartile.
CONCLUSIONS
APC did not reveal additional information to ADR, and thus there is no need to use it instead of or additionally to ADR. Although the APP identifies endoscopists who find few adenomas per procedure despite acceptable ADRs, this additional information might not be important in regard to sufficient colorectal cancer prevention, because these endoscopists still had high advanced ADRs.

Identifiants

pubmed: 30138613
pii: S0016-5107(18)32933-X
doi: 10.1016/j.gie.2018.08.013
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

496-502

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2019. Published by Elsevier Inc.

Auteurs

Irina Gessl (I)

Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Austria Society of Gastroenterology and Hepatology: quality assurance working group, Vienna, Austria.

Elisabeth Waldmann (E)

Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Austria Society of Gastroenterology and Hepatology: quality assurance working group, Vienna, Austria.

Daniela Penz (D)

Austria Society of Gastroenterology and Hepatology: quality assurance working group, Vienna, Austria.

Barbara Majcher (B)

Austria Society of Gastroenterology and Hepatology: quality assurance working group, Vienna, Austria.

Angelika Dokladanska (A)

Austria Society of Gastroenterology and Hepatology: quality assurance working group, Vienna, Austria.

Anna Hinterberger (A)

Austria Society of Gastroenterology and Hepatology: quality assurance working group, Vienna, Austria.

Aleksandra Szymanska (A)

Austria Society of Gastroenterology and Hepatology: quality assurance working group, Vienna, Austria.

Arnulf Ferlitsch (A)

Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria.

Michael Trauner (M)

Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Austria Society of Gastroenterology and Hepatology: quality assurance working group, Vienna, Austria.

Monika Ferlitsch (M)

Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, Vienna, Austria; Austria Society of Gastroenterology and Hepatology: quality assurance working group, Vienna, Austria.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH